ProQR Therapeutics NV (PRQR)
1.84
-0.02
(-1.08%)
USD |
NASDAQ |
Sep 15, 16:00
1.96
+0.12
(+6.52%)
Pre-Market: 08:01
ProQR Therapeutics Market Cap : 259.66M for Sept. 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 259.66M |
| September 14, 2026 | 262.49M |
| September 11, 2026 | 262.49M |
| September 10, 2026 | 273.78M |
| September 09, 2026 | 280.83M |
| September 08, 2026 | 289.30M |
| September 04, 2026 | 292.12M |
| September 03, 2026 | 294.94M |
| September 02, 2026 | 303.41M |
| September 01, 2026 | 299.18M |
| August 31, 2026 | 300.59M |
| August 28, 2026 | 323.17M |
| August 27, 2026 | 327.40M |
| August 26, 2026 | 331.64M |
| August 25, 2026 | 335.87M |
| August 24, 2026 | 342.93M |
| August 21, 2026 | 330.22M |
| August 20, 2026 | 320.35M |
| August 19, 2026 | 313.29M |
| August 18, 2026 | 303.41M |
| August 17, 2026 | 272.36M |
| August 14, 2026 | 270.95M |
| August 13, 2026 | 261.07M |
| August 12, 2026 | 262.49M |
| August 11, 2026 | 270.95M |
| Date | Value |
|---|---|
| August 10, 2026 | 190.71M |
| August 07, 2026 | 197.55M |
| August 06, 2026 | 200.19M |
| August 05, 2026 | 207.56M |
| August 04, 2026 | 192.81M |
| August 03, 2026 | 180.17M |
| July 31, 2026 | 181.22M |
| July 30, 2026 | 187.55M |
| July 29, 2026 | 182.28M |
| July 28, 2026 | 185.44M |
| July 27, 2026 | 182.28M |
| July 24, 2026 | 181.22M |
| July 23, 2026 | 188.60M |
| July 22, 2026 | 190.71M |
| July 21, 2026 | 198.08M |
| July 20, 2026 | 185.44M |
| July 17, 2026 | 179.12M |
| July 16, 2026 | 175.96M |
| July 15, 2026 | 186.49M |
| July 14, 2026 | 179.12M |
| July 13, 2026 | 179.12M |
| July 10, 2026 | 182.28M |
| July 09, 2026 | 185.44M |
| July 08, 2026 | 177.01M |
| July 07, 2026 | 174.90M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pharming Group NV | 746.71M |
| NewAmsterdam Pharma Co. NV | 2.490B |
| argenx SE | 60.63B |
| Mirum Pharmaceuticals, Inc. | 6.080B |
| ACADIA Pharmaceuticals, Inc. | 4.606B |
Market Cap Related Metrics
| PS Ratio | 9.113 |
| PEG Ratio | -0.8667 |
| Price to Book Value | 2.858 |
| Price | 1.84 |
| Earnings Yield | -25.21% |
| PEGY Ratio | -0.8667 |